Dapsone 8.5% / Niacinamide 4%
Product Images NDC 72934-1066

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dapsone 8.5% / Niacinamide 4% (NDC 72934-1066). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sincerus Florida, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

F (1066 2 End)

Label text on a DAPSONE 8.5% / NIACINAMIDE 4% topical product by Sincerus Florida, LLC includes directions for use, such as applying topically as directed by a physician and washing hands after use. It also provides storage instructions and contact information for reporting adverse reactions.*

FDA Label Image

D (1066 2 Front)

Packaging label of DAPSONE 8.5% / NIACINAMIDE 4% gel, 30 gm, by Sincerus Florida, LLC. The white cylindrical container displays the product's NDC number 72934-1066-2 and states it is a compounded drug made in the USA. The label features the Sincerus Florida logo with teal and orange colors.*

FDA Label Image

D (1066 2 Middle)

Close-up image of DAPSONE 8.5% / NIACINAMIDE 4% topical gel label from Sincerus Florida, LLC shows the active ingredients as Dapsone USP 8.5% and Niacinamide USP 4%, plus inactive ingredients Propylene Glycol USP 5% and Suspensisse Gel 82.5%. The label also displays manufacture and lot details partially visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.